ORGANON ZEMURON (ROCURONIUM) SHIPMENTS TO BEGIN BY EARLY APRIL
Executive Summary
ORGANON ZEMURON (ROCURONIUM) SHIPMENTS TO BEGIN BY EARLY APRIL following FDA approval of the neuromuscular blocker March 17. Organon has scheduled its sales force launch meeting for the week of March 21; the Akzo subsidiary said it expects shipments of Zemuron in 5 ml vials (10 mg/ml) to begin on or about April 1. The Zemuron NDA (20-214) was submitted June 29.